Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Neuropharmacology
  4. Volume 22, Issue 1
  5. Article
Volume 22, Issue 1
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

The International Association for the Study of Pain (IASP) defines neuropathic pain as pain caused by a lesion or disease of the somatosensory nervous system. It is characterized as a clinical condition in which diagnostic studies reveal an underlying cause of an abnormality in the peripheral or central nervous system. Many common causes of neuropathic pain in adults are rare in children. The purpose of this focused narrative review is, to 1) provide an overview of neuropathic pain in children, 2) highlight unique considerations related to the diagnosis and mechanisms of neuropathic pain in children, and 3) perform a comprehensive analysis of the pharmacological treatments available. We emphasize that data for routine use of pharmacological agents in children with neuropathic pain are largely inferred from adult literature with little research performed on pediatric populations, yet have clear evidence of harms to pediatric patients. Based on these findings, we propose risk mitigation strategies such as utilizing topical treatments whenever possible, assessing pain phenotyping to guide drug class choice, and considering pharmaceuticals in the broader context of the multidisciplinary treatment of pediatric pain. Furthermore, we highlight important directions for future research on pediatric neuropathic pain treatment.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/1570159X21666230804110858
2024-01-01
2024-10-13

  • From This Site

    /content/journals/cn/10.2174/1570159X21666230804110858
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. PainN. International Association for the Study of Pain.Available from: https://www.iasp-pain.org/resources/terminology/#Neuro-pathicpain
    [Google Scholar]
  2. JensenT.S. BaronR. HaanpääM. KalsoE. LoeserJ.D. RiceA.S.C. TreedeR.D. A new definition of neuropathic pain.Pain2011152102204220510.1016/j.pain.2011.06.01721764514
     [Google Scholar]
  3. LoeserJ.D. A new way of thinking about pains.Pain202216391670167410.1097/j.pain.000000000000258335984381
     [Google Scholar]
  4. ShraimM.A. Massé-AlarieH. HodgesP.W. Methods to discriminate between mechanism-based categories of pain experienced in the musculoskeletal system: A systematic review.Pain202116241007103710.1097/j.pain.000000000000211333136983
     [Google Scholar]
  5. HowardR.F. WienerS. WalkerS.M. Neuropathic pain in children.Arch. Dis. Child.2014991848910.1136/archdischild‑2013‑30420824114955
     [Google Scholar]
  6. IngelmoP.M. FumagalliR. Neuropathic pain in children.Minerva Anestesiol.200470539339815181421
     [Google Scholar]
  7. WalkerS.M. Neuropathic pain in children: Steps towards improved recognition and management.EBioMedicine20206210312410.1016/j.ebiom.2020.10312433248373
     [Google Scholar]
  8. WalcoG.A. DworkinR.H. KraneE.J. LeBelA.A. TreedeR.D. Neuropathic pain in children: Special considerations.Mayo Clin. Proc.2010853S33S4110.4065/mcp.2009.064720194147
     [Google Scholar]
  9. KonijnenbergA.Y. UiterwaalC.S. KimpenJ.L. van der HoevenJ. BuitelaarJ.K. de Graeff-MeederE.R. Children with unexplained chronic pain: Substantial impairment in everyday life.Arch. Dis. Child.200590768068610.1136/adc.2004.05682015899922
     [Google Scholar]
  10. FriedrichsdorfS. GiordanoJ. Desai DakojiK. WarmuthA. DaughtryC. SchulzC. Chronic pain in children and adolescents: Diagnosis and treatment of primary pain disorders in head, abdomen, muscles and joints.Children (Basel)2016344210.3390/children304004227973405
     [Google Scholar]
  11. BaronR. TölleT.R. GockelU. BroszM. FreynhagenR. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms.Pain20091461344010.1016/j.pain.2009.06.00119592166
     [Google Scholar]
  12. GottrupH. KristensenA.D. BachF.W. JensenT.S. Aftersensations in experimental and clinical hypersensitivity.Pain20031031576410.1016/S0304‑3959(02)00415‑312749959
     [Google Scholar]
  13. KatzJ. MelzackR. Referred sensations in chronic pain patients.Pain1987281515910.1016/0304‑3959(87)91059‑13822494
     [Google Scholar]
  14. AnghelescuD.L. SteenB.D. WuH. WuJ. DawN.C. RaoB.N. NeelM.D. NavidF. Prospective study of neuropathic pain after definitive surgery for extremity osteosarcoma in a pediatric population.Pediatr. Blood Cancer2017643e2616210.1002/pbc.2616227573717
     [Google Scholar]
  15. YeungK.K. EngleL. RabelA. AdamsonK. SchwellnusH. EvansC. It just feels weird!: A qualitative study of how children aged 10-18 years describe neuropathic pain.Disabil. Rehabil.201739171695170210.1080/09638288.2016.120710727684213
     [Google Scholar]
  16. Voepel-LewisT. MerkelS. TaitA.R. TrzcinkaA. MalviyaS. The reliability and validity of the Face, Legs, Activity, Cry, Consolability observational tool as a measure of pain in children with cognitive impairment.Anesth. Analg.20029551224122910.1097/00000539‑200211000‑0002012401598
     [Google Scholar]
  17. McGrathP.J. WalcoG.A. TurkD.C. DworkinR.H. BrownM.T. DavidsonK. EcclestonC. FinleyG.A. GoldschneiderK. HaverkosL. HertzS.H. LjungmanG. PalermoT. RappaportB.A. RhodesT. SchechterN. ScottJ. SethnaN. SvenssonO.K. StinsonJ. von BaeyerC.L. WalkerL. WeismanS. WhiteR.E. ZajicekA. ZeltzerL. Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations.J. Pain20089977178310.1016/j.jpain.2008.04.00718562251
     [Google Scholar]
  18. RomanòC.L. RomanòD. LacerenzaM. Antineuropathic and antinociceptive drugs combination in patients with chronic low back pain: A systematic review.Pain Res. Treat.201220121810.1155/2012/15478122619711
     [Google Scholar]
  19. FinnerupN.B. KunerR. JensenT.S. Neuropathic pain: From mechanisms to treatment.Physiol. Rev.2021101125930110.1152/physrev.00045.201932584191
     [Google Scholar]
  20. BennettM. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.Pain200192114715710.1016/S0304‑3959(00)00482‑611323136
     [Google Scholar]
  21. BouhassiraD. AttalN. AlchaarH. BoureauF. BrochetB. BruxelleJ. CuninG. FermanianJ. GiniesP. Grun-OverdykingA. Jafari-SchluepH. Lantéri-MinetM. LaurentB. MickG. SerrieA. ValadeD. VicautE. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).Pain20051141293610.1016/j.pain.2004.12.01015733628
     [Google Scholar]
  22. KrauseS.J. BackonjaM.M. Development of a neuropathic pain questionnaire.Clin. J. Pain200319530631410.1097/00002508‑200309000‑0000412966256
     [Google Scholar]
  23. FinnerupN.B. HaroutounianS. KamermanP. BaronR. BennettD.L.H. BouhassiraD. CruccuG. FreemanR. HanssonP. NurmikkoT. RajaS.N. RiceA.S.C. SerraJ. SmithB.H. TreedeR.D. JensenT.S. Neuropathic pain: An updated grading system for research and clinical practice.Pain201615781599160610.1097/j.pain.000000000000049227115670
     [Google Scholar]
  24. TreedeR.D. JensenT.S. CampbellJ.N. CruccuG. DostrovskyJ.O. GriffinJ.W. HanssonP. HughesR. NurmikkoT. SerraJ. Neuropathic pain: Redefinition and a grading system for clinical and research purposes.Neurology200870181630163510.1212/01.wnl.0000282763.29778.5918003941
     [Google Scholar]
  25. BouhassiraD. AttalN. Diagnosis and assessment of neuropathic pain: The saga of clinical tools.Pain20111523S74S8310.1016/j.pain.2010.11.02721185120
     [Google Scholar]
  26. RolkeR. BaronR. MaierC. TölleT.R. TreedeD.R. BeyerA. BinderA. BirbaumerN. BirkleinF. BötefürI.C. BrauneS. FlorH. HugeV. KlugR. LandwehrmeyerG.B. MagerlW. MaihöfnerC. RolkoC. SchaubC. ScherensA. SprengerT. ValetM. WasserkaB. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values.Pain2006123323124310.1016/j.pain.2006.01.04116697110
     [Google Scholar]
  27. BlankenburgM. BoekensH. HechlerT. MaierC. KrumovaE. ScherensA. MagerlW. AksuF. ZernikowB. Reference values for quantitative sensory testing in children and adolescents: Developmental and gender differences of somatosensory perception.Pain20101491768810.1016/j.pain.2010.01.01120138430
     [Google Scholar]
  28. RamaswamyS. WodehouseT. Conditioned pain modulation-A comprehensive review.Neurophysiol. Clin.202151319720810.1016/j.neucli.2020.11.00233334645
     [Google Scholar]
  29. BruneauA. CarriéS. MoscaritoloL. IngelmoP. Mechanism-based pharmacological treatment for chronic non-cancer pain in adolescents: Current approaches and future directions.Paediatr. Drugs202224657358310.1007/s40272‑022‑00534‑x36053398
     [Google Scholar]
  30. BruneauA. FerlandC.E. Pérez-Medina-CarballoR. SomainiM. MohamedN. CuratoloM. OuelletJ.A. IngelmoP. Association between the use of quantitative sensory testing and conditioned pain modulation and the prescription of medication and interventional procedures in children with chronic pain conditions.Children (Basel)202298115710.3390/children908115736010048
     [Google Scholar]
  31. CollocaL. LudmanT. BouhassiraD. BaronR. DickensonA.H. YarnitskyD. FreemanR. TruiniA. AttalN. FinnerupN.B. EcclestonC. KalsoE. BennettD.L. DworkinR.H. RajaS.N. Neuropathic pain.Nat. Rev. Dis. Primers2017311700210.1038/nrdp.2017.228205574
     [Google Scholar]
  32. Kocot-Kępska, M.; Zajączkowska, R.; Mika, J.; Wordliczek, J.; Dobrogowski, J.; Przeklasa-Muszyńska, A. Peripheral mechanisms of neuropathic pain-the role of neuronal and non-neuronal interactions and their implications for topical treatment of neuropathic pain.Pharmaceuticals (Basel)20211427710.3390/ph1402007733498496
     [Google Scholar]
  33. BurmaN.E. Leduc-PessahH. FanC.Y. TrangT. Animal models of chronic pain: Advances and challenges for clinical translation.J. Neurosci. Res.20179561242125610.1002/jnr.2376827376591
     [Google Scholar]
  34. JaggiA.S. JainV. SinghN. Animal models of neuropathic pain.Fundam. Clin. Pharmacol.201125112810.1111/j.1472‑8206.2009.00801.x20030738
     [Google Scholar]
  35. DecosterdI. WoolfC.J. Spared nerve injury: An animal model of persistent peripheral neuropathic pain.Pain200087214915810.1016/S0304‑3959(00)00276‑110924808
     [Google Scholar]
  36. BennettG.J. XieY.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.Pain19883318710710.1016/0304‑3959(88)90209‑62837713
     [Google Scholar]
  37. GilronI. BaronR. JensenT. Neuropathic pain: Principles of diagnosis and treatment.Mayo Clin. Proc.201590453254510.1016/j.mayocp.2015.01.01825841257
     [Google Scholar]
  38. RirieD.G. EisenachJ.C. Age-dependent responses to nerve injury-induced mechanical allodynia.Anesthesiology2006104234435010.1097/00000542‑200602000‑0002116436855
     [Google Scholar]
  39. LeeD.H. ChungJ.M. Neuropathic pain in neonatal rats.Neurosci. Lett.1996209214014210.1016/0304‑3940(96)12623‑98762002
     [Google Scholar]
  40. HowardR.F. WalkerS.M. MotaM.P. FitzgeraldM. The ontogeny of neuropathic pain: Postnatal onset of mechanical allodynia in rat spared nerve injury (SNI) and chronic constriction injury (CCI) models.Pain2005115338238910.1016/j.pain.2005.03.01615911165
     [Google Scholar]
  41. FitzgeraldM. McKelveyR. Nerve injury and neuropathic pain-A question of age.Exp. Neurol.2016275Pt 229630210.1016/j.expneurol.2015.07.01326220898
     [Google Scholar]
  42. AnandP. BirchR. Restoration of sensory function and lack of long-term chronic pain syndromes after brachial plexus injury in human neonates.Brain2002125111312210.1093/brain/awf01711834597
     [Google Scholar]
  43. AthertonD.D. TaherzadehO. ElliotD. AnandP. Age-dependent development of chronic neuropathic pain, allodynia and sensory recovery after upper limb nerve injury in children.J. Hand Surg. Eur. Vol.200833218619110.1177/175319340808702918443061
     [Google Scholar]
  44. Vega-AvelairaD. McKelveyR. HathwayG. FitzgeraldM. The emergence of adolescent onset pain hypersensitivity following neonatal nerve injury.Mol. Pain201281744-8069-8-3010.1186/1744‑8069‑8‑3022531549
     [Google Scholar]
  45. McKelveyR. BertaT. OldE. JiR.R. FitzgeraldM. Neuropathic pain is constitutively suppressed in early life by anti-inflammatory neuroimmune regulation.J. Neurosci.201535245746610.1523/JNEUROSCI.2315‑14.201525589741
     [Google Scholar]
  46. HermannC. HohmeisterJ. DemirakçaS. ZohselK. FlorH. Long-term alteration of pain sensitivity in school-aged children with early pain experiences.Pain2006125327828510.1016/j.pain.2006.08.02617011707
     [Google Scholar]
  47. BeggsS. CurrieG. SalterM.W. FitzgeraldM. WalkerS.M. Priming of adult pain responses by neonatal pain experience: maintenance by central neuroimmune activity.Brain2012135240441710.1093/brain/awr28822102650
     [Google Scholar]
  48. RenK. AnseloniV. ZouS.P. WadeB.E. NovikovaI.S. EnnisM. TraubJ.R. GoldS.M. DubnerR. LidowS.M. Characterization of basal and re-inflammation-associated long-term alteration in pain responsivity following short-lasting neonatal local inflamatory insult.Pain2004110358859610.1016/j.pain.2004.04.00615288399
     [Google Scholar]
  49. TaddioA. GoldbachM. IppM. StevensB. KorenG. Effect of neonatal circumcision on pain responses during vaccination in boys.Lancet1995345894529129210.1016/S0140‑6736(95)90278‑37837863
     [Google Scholar]
  50. ScheffelJ. RegenT. Van RossumD. SeifertS. RibesS. NauR. ParsaR. HarrisR.A. BoddekeH.W.G.M. ChuangH.N. PukropT. WesselsJ.T. JürgensT. MerklerD. BrückW. SchnaarsM. SimonsM. KettenmannH. HanischU.K. Toll-like receptor activation reveals developmental reorganization and unmasks responder subsets of microglia.Glia201260121930194310.1002/glia.2240922911652
     [Google Scholar]
  51. MelzackR. IsraelR. LacroixR. SchultzG. Phantom limbs in people with congenital limb deficiency or amputation in early childhood.Brain199712091603162010.1093/brain/120.9.16039313643
     [Google Scholar]
  52. CooperT.E. WiffenP.J. HeathcoteL.C. ClinchJ. HowardR. KraneE. LordS.M. SethnaN. SchechterN. WoodC. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.Cochrane Libr.201788CD01253610.1002/14651858.CD012536.pub228779491
     [Google Scholar]
  53. CooperT.E. HeathcoteL.C. ClinchJ. GoldJ.I. HowardR. LordS.M. SchechterN. WoodC. WiffenP.J. Antidepressants for chronic non-cancer pain in children and adolescents.Cochrane Database Syst. Rev.201788CD01253528779487
     [Google Scholar]
  54. CooperT.E. FisherE. GrayA.L. KraneE. SethnaN. van TilburgM.A. ZernikowB. WiffenP.J. Opioids for chronic non-cancer pain in children and adolescents.Cochrane Database Syst. Rev.201777CD01253828745394
     [Google Scholar]
  55. EcclestonC. FisherE. CooperT.E. GrégoireM.C. HeathcoteL.C. KraneE. LordS.M. SethnaN.F. AndersonA.K. AndersonB. ClinchJ. GrayA.L. GoldJ.I. HowardR.F. LjungmanG. MooreR.A. SchechterN. WiffenP.J. WilkinsonN.M.R. WilliamsD.G. WoodC. van TilburgM.A.L. ZernikowB. Pharmacological interventions for chronic pain in children: An overview of systematic reviews.Pain201916081698170710.1097/j.pain.000000000000160931335640
     [Google Scholar]
  56. World Health OrganizationGuidelines on the management of chronic pain in children.2020Available from: https://www.who.int/publications/i/item/9789240017870
    [Google Scholar]
  57. TaylorC.P. Mechanisms of action of gabapentin.Rev. Neurol. (Paris)1997153Suppl. 1S39S459686247
     [Google Scholar]
  58. AbdiS. LeeD.H. ChungJ.M. The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain.Anesth. Analg.19988761360136610.1213/00000539‑199812000‑000279842827
     [Google Scholar]
  59. DonadoC. NedeljkovicK. WangnamthipS. SolodiukJ.C. BourgeoisF.T. BerdeC.B. Trends in gabapentin and pregabalin prescribing in a tertiary pediatric medical center.Hosp. Pediatr.202111890991410.1542/hpeds.2020‑00358234257145
     [Google Scholar]
  60. AkkurtH.E. Gümüş H.; Göksu, H.; Odabaşı Ö.F.; Yılmaz, H. Gabapentin treatment for neuropathic pain in a child with sciatic nerve injury.Case Rep. Med.201520151310.1155/2015/87315726346828
     [Google Scholar]
  61. SaroyanJ.M. WinfreeC.J. SchechterW.S. RoyeD. GoldA.P. Sciatic neuropathy after lower-extremity trauma: successful treatment of an uncommon pain and disability syndrome in an adolescent.Am. J. Phys. Med. Rehabil.200786759760010.1097/PHM.0b013e31806dbdd217581294
     [Google Scholar]
  62. RiesM. MengelE. KutschkeG. KimK.S. BirkleinF. KrummenauerF. BeckM. Use of gabapentin to reduce chronic neuropathic pain in Fabry disease.J. Inherit. Metab. Dis.200326441341410.1023/A:102512772372912971431
     [Google Scholar]
  63. RusyL.M. TroshynskiT.J. WeismanS.J. Gabapentin in phantom limb pain management in children and young adults: report of seven cases.J. Pain Symptom Manage.2001211788210.1016/S0885‑3924(00)00243‑811223317
     [Google Scholar]
  64. KaulI. AminA. RosenbergM. RosenbergL. MeyerW.J.III Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review.Burns201844241442210.1016/j.burns.2017.07.01828822592
     [Google Scholar]
  65. VondracekP. OslejskovaH. KepakT. MazanekP. SterbaJ. RysavaM. GalP. Efficacy of pregabalin in neuropathic pain in paediatric oncological patients.Eur. J. Paediatr. Neurol.200913433233610.1016/j.ejpn.2008.06.01118774740
     [Google Scholar]
  66. AnghelescuD.L. FaughnanL.G. JehaS. RellingM.V. HindsP.S. SandlundJ.T. ChengC. PeiD. HankinsG. PauleyJ.L. PuiC.H. Neuropathic pain during treatment for childhood acute lymphoblastic leukemia.Pediatr. Blood Cancer20115771147115310.1002/pbc.2303921319291
     [Google Scholar]
  67. AnghelescuD.L. TesneyJ.M. JehaS. WrightB.B. TrujilloL. SandlundJ.T. PauleyJ. ChengC. PeiD. PuiC.H. Prospective randomized trial of interventions for vincristine‐related neuropathic pain.Pediatr. Blood Cancer2020679e2853910.1002/pbc.2853932618122
     [Google Scholar]
  68. AnghelescuD.L. TesneyJ.M. Neuropathic pain in pediatric oncology: A clinical decision algorithm.Paediatr. Drugs2019212597010.1007/s40272‑018‑00324‑430761460
     [Google Scholar]
  69. FriedrichsdorfS.J. NugentA.P. Management of neuropathic pain in children with cancer.Curr. Opin. Support. Palliat. Care20137213113810.1097/SPC.0b013e3283615ebe23635878
     [Google Scholar]
  70. ColuzziF. RoccoM. Green GladdenR. PersianiP. ThurL.A. MilanoF. Pain management in childhood leukemia: Diagnosis and available analgesic treatments.Cancers (Basel)20201212367110.3390/cancers1212367133297484
     [Google Scholar]
  71. BrownS. JohnstonB. AmariaK. WatkinsJ. CampbellF. PehoraC. McGrathP. A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children.Scand. J. Pain201613115616310.1016/j.sjpain.2016.05.03928850523
     [Google Scholar]
  72. MoleroY. LarssonH. D’OnofrioB.M. SharpD.J. FazelS. Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: Population based cohort study in Sweden.BMJ2019365l214710.1136/bmj.l214731189556
     [Google Scholar]
  73. M PeckhamA. AnanickalM. SclarD. Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance.Risk Manag. Healthc. Policy20181110911610.2147/RMHP.S16850430154674
     [Google Scholar]
  74. LiD. HuangS. WangX. YangL. SongT. Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children.Front. Neurol.20221392405710.3389/fneur.2022.92405735968281
     [Google Scholar]
  75. De CaroC. CristianoC. AvaglianoC. CuozzoM. La RanaG. AvielloG. De SarroG. CalignanoA. RussoE. RussoR. Analgesic and anti-inflammatory effects of perampanel in acute and chronic pain models in mice: interaction with the cannabinergic system.Front. Pharmacol.20211162022110.3389/fphar.2020.62022133597883
     [Google Scholar]
  76. KhanguraR.K. BaliA. KaurG. SinghN. JaggiA.S. Neuropathic pain attenuating effects of perampanel in an experimental model of chronic constriction injury in rats.Biomed. Pharmacother.20179455756310.1016/j.biopha.2017.07.13728780471
     [Google Scholar]
  77. HaraK. HaranishiY. TeradaT. Intrathecally administered perampanel alleviates neuropathic and inflammatory pain in rats.Eur. J. Pharmacol.202087217294910.1016/j.ejphar.2020.17294931991141
     [Google Scholar]
  78. ChangM.C. ParkD. Effectiveness of perampanel in managing chronic pain caused by the complex regional pain syndrome.Medicine (Baltimore)202110048e2779110.1097/MD.000000000002779135049177
     [Google Scholar]
  79. FinnerupN.B. AttalN. HaroutounianS. McNicolE. BaronR. DworkinR.H. GilronI. HaanpääM. HanssonP. JensenT.S. KamermanP.R. LundK. MooreA. RajaS.N. RiceA.S.C. RowbothamM. SenaE. SiddallP. SmithB.H. WallaceM. Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis.Lancet Neurol.201514216217310.1016/S1474‑4422(14)70251‑025575710
     [Google Scholar]
  80. National Institute for Health and Care ExcellenceNeuropathic pain in adults: pharacological management in non-specialist settings.Available from: https://www.nice.org.uk/guidance/cg173/chapter/Recommendations
    [Google Scholar]
  81. BatesD. SchultheisB.C. HanesM.C. JollyS.M. ChakravarthyK.V. DeerT.R. LevyR.M. HunterC.W. A comprehensive algorithm for management of neuropathic pain.Pain Med.201920Suppl. 1S2S1210.1093/pm/pnz07531152178
     [Google Scholar]
  82. MoulinD.E. BoulangerA. ClarkA.J. ClarkeH. DaoT. FinleyG.A. FurlanA. GilronI. GordonA. Morley-ForsterP.K. SessleB.J. SquireP. StinsonJ. TaenzerP. VellyA. WareM.A. WeinbergE.L. WilliamsonO.D. Pharmacological management of chronic neuropathic pain: Revised consensus statement from the Canadian Pain Society.Pain Res. Manag.201419632833510.1155/2014/75469325479151
     [Google Scholar]
  83. WindsorR.B. SierraM. ZappitelliM. McDanielM. Beyond Amitriptyline: A pediatric and adolescent oriented narrative review of the analgesic properties of psychotropic medications for the treatment of complex pain and headache disorders.Children (Basel)202071226810.3390/children712026833276542
     [Google Scholar]
  84. JacksonK.C.II St OngeE.L. Antidepressant pharmacotherapy: Considerations for the pain clinician.Pain Pract.20033213514310.1046/j.1533‑2500.2003.03020.x17163912
     [Google Scholar]
  85. SapsM. YoussefN. MirandaA. NurkoS. HymanP. CocjinJ. Di LorenzoC. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders.Gastroenterology200913741261126910.1053/j.gastro.2009.06.06019596010
     [Google Scholar]
  86. de BruijnC.M. RexwinkelR. GordonM. BenningaM. TabbersM.M. Antidepressants for functional abdominal pain disorders in children and adolescents.Cochrane Database Syst Rev.202122CD008013.2
     [Google Scholar]
  87. WilderR.T. BerdeC.B. WolohanM. VieyraM.A. MasekB.J. MicheliL.J. Reflex sympathetic dystrophy in children. Clinical characteristics and follow-up of seventy patients.J. Bone Joint Surg. Am.199274691091910.2106/00004623‑199274060‑000131634582
     [Google Scholar]
  88. PoliteiJ.M. BouhassiraD. GermainD.P. GoizetC. Guerrero-SolaA. HilzM.J. HuttonE.J. KaraaA. LiguoriR. ÜçeylerN. ZeltzerL.K. BurlinaA. Pain in fabry disease: Practical recommendations for diagnosis and treatment.CNS Neurosci. Ther.201622756857610.1111/cns.1254227297686
     [Google Scholar]
  89. MooreR.A. DerryS. AldingtonD. ColeP. WiffenP.J. Amitriptyline for neuropathic pain in adults.Cochrane Database Syst. Rev.201520157CD00824226146793
     [Google Scholar]
  90. MooreR.A. DerryS. AldingtonD. ColeP. WiffenP.J. Amitriptyline for neuropathic pain and fibromyalgia in adults.Cochrane Database Syst. Rev.201212CD00824223235657
     [Google Scholar]
  91. HearnL. MooreR.A. DerryS. WiffenP.J. PhillipsT. Desipramine for neuropathic pain in adults.Cochrane Database Syst. Rev.201420149CD01100325246131
     [Google Scholar]
  92. DharmshaktuP. TayalV. KalraB.S. Efficacy of antidepressants as analgesics: A review.J. Clin. Pharmacol.201252161710.1177/009127001039485221415285
     [Google Scholar]
  93. MaxM.B. LynchS.A. MuirJ. ShoafS.E. SmollerB. DubnerR. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.N. Engl. J. Med.1992326191250125610.1056/NEJM1992050732619041560801
     [Google Scholar]
  94. LunnM.P. HughesR.A. WiffenP.J. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.Cochrane Database Syst Rev. 2201431CD00711510.1002/14651858.CD007115.pub324385423
     [Google Scholar]
  95. OkumaK. ShiraishiK. KanaiY. NakagawaK. Improvement in quality of life by using duloxetine for chemotherapy-induced peripheral neuropathy (CIPN): A case report.Support. Care Cancer201624114483448510.1007/s00520‑016‑3349‑127448406
     [Google Scholar]
  96. MengJ. ZhangQ. YangC. XiaoL. XueZ. ZhuJ. Duloxetine, a balanced serotonin-norepinephrine reuptake inhibitor, improves painful chemotherapy-induced peripheral neuropathy by inhibiting activation of p38 MAPK and NF-κB.Front. Pharmacol.20191036510.3389/fphar.2019.0036531024320
     [Google Scholar]
  97. MeighenK.G. Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder.J. Child Adolesc. Psychopharmacol.200717112112710.1089/cap.2006.004217343560
     [Google Scholar]
  98. DesarkarP. DasA. SinhaV.K. Duloxetine for childhood depression with pain and dissociative symptoms.Eur. Child Adolesc. Psychiatry200615849649910.1007/s00787‑006‑0553‑416732464
     [Google Scholar]
  99. KachkoL. Ben AmiS. LibermanA. BirkE. KronenbergS. Duloxetine contributing to a successful multimodal treatment program for peripheral femoral neuropathy and comorbid ‘reactive depression’ in an adolescent.Pain Res. Manag.201116645745910.1155/2011/16498422184557
     [Google Scholar]
  100. BurghardtK.J. ThomasS.T. Tutag-LehrV. Off-label use of duloxetine for pediatric neuropathic pain.Ment. Health Clin.20155627728310.9740/mhc.2015.11.277
     [Google Scholar]
  101. BaigM.U. MaddenK. MoodyK. Hyponatremia with antidepressant: A rare side effect from duloxetine in a child with acute leukemia.J. Palliat. Med.202225121884188710.1089/jpm.2021.052635537479
     [Google Scholar]
  102. SemenchukM.R. DavisB. Efficacy of sustained-release bupropion in neuropathic pain: An open-label study.Clin. J. Pain200016161110.1097/00002508‑200003000‑0000210741812
     [Google Scholar]
  103. SemenchukM.R. ShermanS. DavisB. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain.Neurology20015791583158810.1212/WNL.57.9.158311706096
     [Google Scholar]
  104. ValentinoR.J. VolkowN.D. Untangling the complexity of opioid receptor function.Neuropsychopharmacology201843132514252010.1038/s41386‑018‑0225‑330250308
     [Google Scholar]
  105. WindsorR.B. ThamS.W. AdamsT.L. AndersonA. The use of opioids for treatment of pediatric neuropathic pain.Clin. J. Pain201935650951410.1097/AJP.000000000000071230985402
     [Google Scholar]
  106. McNicolE.D. MidbariA. EisenbergE. Opioids for neuropathic pain.Cochrane Database Syst. Rev.201320138CD00614623986501
     [Google Scholar]
  107. DuehmkeR.M. DerryS. WiffenP.J. BellR.F. AldingtonD. MooreR.A. Tramadol for neuropathic pain in adults.Cochrane Database Syst. Rev.201766CD00372628616956
     [Google Scholar]
  108. FDA Drug Safety CommunicationFDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children.Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020281s039lbl.pdf
    [Google Scholar]
  109. FinkelJ.C. GoldbergJ. RosenburgR. AriyawansaJ. SunT. Ochs-RossR. ZannikosP. ZhangL. EtropolskiM. First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18.J. Pain Res.2019121925193610.2147/JPR.S19734831303784
     [Google Scholar]
  110. MuseD. TarauE. LefeberC. SohnsM. BrettM. GoldbergJ. RosenburgR. Pharmacokinetics, safety, and efficacy of tapentadol oral solution for treating moderate to severe pain in pediatric patients.J. Pain Res.2019121777179010.2147/JPR.S19703931213888
     [Google Scholar]
  111. JohnsonP.N. BoylesK.A. MillerJ.L. Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children.Pharmacotherapy201232214815710.1002/PHAR.100122392424
     [Google Scholar]
  112. TobiasJ.D. Methadone: Applications in pediatric anesthesiology and critical care medicine.J. Anesth.202135113014110.1007/s00540‑020‑02887‑433432486
     [Google Scholar]
  113. DervanL.A. YaghmaiB. WatsonR.S. WolfF.M. The use of methadone to facilitate opioid weaning in pediatric critical care patients: A systematic review of the literature and meta‐analysis.Paediatr. Anaesth.201727322823910.1111/pan.1305628109052
     [Google Scholar]
  114. YeJ. MyungK. PackiasabapathyS. YuJ.S. JacobsonJ.E. WhittakerS.C. CastelluccioP. Drayton JacksonM. SadhasivamS. Methadone-based multimodal analgesia provides the best-in-class acute surgical pain control and functional outcomes with lower opioid use following major posterior fusion surgery in adolescents with idiopathic scoliosis.Pediatr. Qual. Saf.202054e33610.1097/pq9.000000000000033632766507
     [Google Scholar]
  115. Boisvert-PlanteV. Poulin-HarnoisC. IngelmoP. EinhornL.M. What we know and what we don’t know about the perioperative use of methadone in children and adolescents.Paediatr. Anaesth.202236281540
     [Google Scholar]
  116. FriedrichsdorfS.J. KangT.I. The management of pain in children with life-limiting illnesses.Pediatr. Clin. North Am.2007545645672x.10.1016/j.pcl.2007.07.00717933616
     [Google Scholar]
  117. AnghelescuD.L. FaughnanL.G. HankinsG.M. WardD.A. OakesL.L. Methadone use in children and young adults at a cancer center: A retrospective study.J. Opioid. Manag.20117535336110.5055/jom.2011.007622165034
     [Google Scholar]
  118. HallE.A. SauerH.E. HabashyC. AnghelescuD.L. Methadone for cancer pain in pediatric end-of-life care.Am. J. Hosp. Palliat. Care202138891491910.1177/104990912096364133000633
     [Google Scholar]
  119. HabashyC. SpringerE. HallE.A. AnghelescuD.L. Methadone for pain management in children with cancer.Paediatr. Drugs201820540941610.1007/s40272‑018‑0304‑230047027
     [Google Scholar]
  120. VoT. RiceA.S.C. DworkinR.H. Non-steroidal anti-inflammatory drugs for neuropathic pain: How do we explain continued widespread use?Pain2009143316917110.1016/j.pain.2009.03.01319362418
     [Google Scholar]
  121. MooreR.A. ChiC.C. WiffenP.J. DerryS. RiceA.S. Oral nonsteroidal anti‐inflammatory drugs for neuropathic pain.Cochrane Database Syst. Rev.2015201510CD01090210.1002/14651858.CD010902.pub226436601
     [Google Scholar]
  122. ZamproniL.N. RibeiroR.T. CardealM. Treatment of recurrent painful ophthalmoplegic neuropathy: A case where pregabalin was successfully employed.Case Rep. Neurol. Med.201920191510.1155/2019/918560330881712
     [Google Scholar]
  123. MyersK.A. BarmherzigR. RajN.R. BerrahmouneS. IngelmoP. Saint-MartinC. KhanA.Q. KouriM. MorrisC. HersheyA.D. KacperskiJ. KabboucheM.A. MohamedN. RaoR.R. Lagman-BartolomeA.M. GelfandA.A. SzperkaC.L. OrrS.L. The spectrum of indomethacin-responsive headaches in children and adolescents.Cephalalgia202242879379710.1177/0333102422107648335302385
     [Google Scholar]
  124. HallE.A. SauerH.E. DavisM.S. AnghelescuD.L. Lidocaine infusions for pain management in pediatrics.Paediatr. Drugs202123434935910.1007/s40272‑021‑00454‑234036532
     [Google Scholar]
  125. YangX. WeiX. MuY. LiQ. LiuJ. A review of the mechanism of the central analgesic effect of lidocaine.Medicine (Baltimore)20209917e1989810.1097/MD.000000000001989832332666
     [Google Scholar]
  126. SugimotoM. UchidaI. MashimoT. Local anaesthetics have different mechanisms and sites of action at the recombinant N-methyl-D-aspartate (NMDA) receptors.Br. J. Pharmacol.2003138587688210.1038/sj.bjp.070510712642389
     [Google Scholar]
  127. AraujoM.C. SinnottC.J. StrichartzG.R. Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: responses to early and late infusions.Pain20031031212910.1016/S0304‑3959(02)00350‑012749955
     [Google Scholar]
  128. MasicD. LiangE. LongC. SterkE.J. BarbasB. RechM.A. Intravenous lidocaine for acute pain: A systematic review.Pharmacotherapy201838121250125910.1002/phar.218930303542
     [Google Scholar]
  129. ZhuB. ZhouX. ZhouQ. WangH. WangS. LuoK. Intra-venous lidocaine to relieve neuropathic pain: A systematic review and meta-analysis.Front. Neurol.20191095410.3389/fneur.2019.0095431620064
     [Google Scholar]
  130. KimY.C. CastañedaA.M. LeeC. JinH.S. ParkK.S. MoonJ.Y. Efficacy and safety of lidocaine infusion treatment for neuropathic pain.Reg. Anesth. Pain Med.201843441542410.1097/AAP.000000000000074129381569
     [Google Scholar]
  131. van den HeuvelS.A.S. van der WalS.E.I. SmedesL.A. RademaS.A. van AlfenN. VissersK.C.P. SteegersM.A.H. Intravenous lidocaine: Old-school drug, new purpose-reduction of intractable pain in patients with chemotherapy induced peripheral neuropathy.Pain Res. Manag.20172017805347428458593
     [Google Scholar]
  132. HutsonP. BackonjaM. KnurrH. Intravenous lidocaine for neuropathic pain: A retrospective analysis of tolerability and efficacy.Pain Med.201516353153610.1111/pme.1264225530475
     [Google Scholar]
  133. Tremont-LukatsI.W. HutsonP.R. BackonjaM.M. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain.Clin. J. Pain200622326627110.1097/01.ajp.0000169673.57062.4016514327
     [Google Scholar]
  134. MooneyJ.J. PagelP.S. KunduA. Safety, tolerability, and short-term efficacy of intravenous lidocaine infusions for the treatment of chronic pain in adolescents and young adults: A preliminary report.Pain Med.201415582082510.1111/pme.1233324423053
     [Google Scholar]
  135. PuriL. MorganK.J. AnghelescuD.L. Ketamine and lidocaine infusions decrease opioid consumption during vaso-occlusive crisis in adolescents with sickle cell disease.Curr. Opin. Support. Palliat. Care201913440240710.1097/SPC.000000000000043731157658
     [Google Scholar]
  136. MasseyG.V. PedigoS. DunnN.L. GrossmanN.J. RussellE.C. Continuous lidocaine infusion for the relief of refractory malignant pain in a terminally ill pediatric cancer patient.J. Pediatr. Hematol. Oncol.200224756656810.1097/00043426‑200210000‑0001512368697
     [Google Scholar]
  137. GibbonsK. DeMonbrunA. BeckmanE.J. KeeferP. WagnerD. StewartM. SaulD.A. HakelS. LiuM. NiednerM. Continuous lidocaine infusions to manage opioid-refractory pain in a series of cancer patients in a pediatric hospital.Pediatr. Blood Cancer20166371168117410.1002/pbc.2587026784686
     [Google Scholar]
  138. FeatherlyJ. Baxter WojnowiczS. SteidlK. BurgessJ. Lidocaine for dinutuximab‐associated pain? A multicenter retrospective observational cohort study.Pediatr. Blood Cancer2022699e2965310.1002/pbc.2965335441791
     [Google Scholar]
  139. VoltarelliJ.C. AhmedH. PatonE.J.A. StracieriA.B.P.L. HolmanP. BasheyA. CoutinhoM. SimoesB.P. BallE.D. CarrierE. Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.Bone Marrow Transplant.2001281979910.1038/sj.bmt.170308011498752
     [Google Scholar]
  140. WallaceM.S. LeeJ. SorkinL. DunnJ.S. YakshT. YuA. Intravenous lidocaine.Anesth. Analg.199785479479610.1213/00000539‑199710000‑000149322457
     [Google Scholar]
  141. KajiumeT. SeraY. NakanunoR. OguraT. KarakawaS. KobayakawaM. TaguchiS. OshitaK. KawaguchiH. SatoT. KobayashiM. Continuous intravenous infusion of ketamine and lidocaine as adjuvant analgesics in a 5-year-old patient with neuropathic cancer pain.J. Palliat. Med.201215671972210.1089/jpm.2011.009722401313
     [Google Scholar]
  142. FinholtD.A. StirtJ.A. DiFazioC.A. MoscickiJ.C. Lidocaine pharmacokinetics in children during general anesthesia.Anesth. Analg.198665327928210.1213/00000539‑198603000‑000103954094
     [Google Scholar]
  143. WallaceM.S. DyckB.J. RossiS.S. YakshT.L. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury.Pain1996661697710.1016/0304‑3959(96)02980‑68857633
     [Google Scholar]
  144. BaronR. AllegriM. Correa-IllanesG. HansG. SerpellM. MickG. MayoralV. The 5% lidocaine-medicated plaster: Its inclusion in international treatment guidelines for treating localized neuropathic pain, and clinical evidence supporting its use.Pain Ther.20165214916910.1007/s40122‑016‑0060‑327822619
     [Google Scholar]
  145. AmatoF. DuseG. ConsolettiL. Lo PrestiC. FirettoV. CilibertoG. ParigiL.A. PalmieriV. MazzaM. Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study.Eur. Rev. Med. Pharmacol. Sci.201721184228423529028074
     [Google Scholar]
  146. PalladiniM. BoeslI. KoenigS. BuchheisterB. AttalN. Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: Efficacy and safety results of a randomized, placebo-controlled trial.Curr. Med. Res. Opin.201935575776610.1080/03007995.2019.156570930614286
     [Google Scholar]
  147. RousseauV. MorelleM. ArriubergeC. DarnisS. ChabaudS. LaunayV. ThouveninS. Roumenoff-TurcantF. MetzgerS. TourniaireB. Marec-BerardP. Efficacy and tolerance of lidocaine 5% patches in neuropathic pain and pain related to vaso-occlusive sickle cell crises in children: A prospective multicenter clinical study.Pain Pract.201818678879710.1111/papr.1267429266772
     [Google Scholar]
  148. NayakS. CunliffeM. Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: Report of five cases.Paediatr. Anaesth.200818655455810.1111/j.1460‑9592.2008.02491.x18363625
     [Google Scholar]
  149. RasolofoJ. PonceletM. RousseauV. Marec-BerardP. Analgesic efficacy of topical lidocaine for vaso-occlusive crisis in children with sickle cell disease.Arch. Pediatr.201320776276710.1016/j.arcped.2013.04.01323731603
     [Google Scholar]
  150. GoddardJ.M. ReaneyR.L. Lidocaine 5%-medicated plaster (Versatis) for localised neuropathic pain: results of a multicentre evaluation of use in children and adolescents.Br. J. Pain201812318919310.1177/204946371875643130057764
     [Google Scholar]
  151. HauerJ. HoutrowA.J. FeudtnerC. KleinS. KlickJ. LinebargerJ. NorwoodK.W.Jr AdamsR.C. BreiT.J. DavidsonL.F. DavisB.E. FriedmanS.L. HymanS.L. KuoD.Z. NoritzG.H. YinL. MurphyN.A. Pain assessment and treatment in children with significant impairment of the central nervous system.Pediatrics20171396e2017100210.1542/peds.2017‑100228562301
     [Google Scholar]
  152. BurnsJ. JacksonK. SheehyK.A. FinkelJ.C. QuezadoZ.M. The use of dexmedetomidine in pediatric palliative care: A preliminary study.J. Palliat. Med.201720777978310.1089/jpm.2016.041928186850
     [Google Scholar]
  153. AmmermanS. RyanS. AdelmanW.P. LevyS. AmmermanS.D. GonzalezP.K. RyanS.A. SiqueiraL.M. SmithV.C. BravermanP.K. AdelmanW.P. AldermanE.M. BreunerC.C. LevineD.A. MarcellA.V. O’BrienR.F. The impact of marijuana policies on youth: Clinical, research, and legal update.Pediatrics20151353e769e78510.1542/peds.2014‑414725624383
     [Google Scholar]
  154. TaylorM. JakackiR. MayC. HowrieD. MaurerS. Ketamine PCA for treatment of end-of-life neuropathic pain in pediatrics.Am. J. Hosp. Palliat. Care201532884184810.1177/104990911454364025028743
     [Google Scholar]
  155. BeniniF. CongediS. GiacomelliL. PapaS. ShahA. MilaniG. Refractory symptoms in paediatric palliative care: Can ketamine help?Drugs Context2021101910.7573/dic.2021‑2‑534104198
     [Google Scholar]
  156. SheehyK.A. MullerE.A. LippoldC. NouraieM. FinkelJ.C. QuezadoZ.M.N. Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: A longitudinal study.BMC Pediatr.201515119810.1186/s12887‑015‑0515‑426620833
     [Google Scholar]
  157. DerryS. RiceA.S. ColeP. TanT. MooreR.A. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.Cochrane Database Syst. Rev.201711CD00739328085183
     [Google Scholar]
  158. GlarosA.K. CallaghanM.U. SmithW.R. ZaidiA.U. Targeting TRPV1 activity via high‐dose capsaicin in patients with sickle cell disease.eJHaem20223365365910.1002/jha2.52836051054
     [Google Scholar]
  159. CavalliE. MammanaS. NicolettiF. BramantiP. MazzonE. The neuropathic pain: An overview of the current treatment and future therapeutic approaches.Int. J. Immunopathol. Pharmacol.20193310.1177/205873841983838330900486
     [Google Scholar]
  160. AfshariK. DehdashtianA. HaddadiN.S. Haj-MirzaianA. IranmehrA. EbrahimiM.A. TavangarS.M. Faghir-GhanesefatH. MohammadiF. RahimiN. JavidanA.N. DehpourA.R. Anti-inflammatory effects of Metformin improve the neuropathic pain and locomotor activity in spinal cord injured rats: Introduction of an alternative therapy.Spinal Cord201856111032104110.1038/s41393‑018‑0168‑x29959433
     [Google Scholar]
  161. VieiraG. CavalliJ. GonçalvesE.C.D. GonçalvesT.R. LaurindoL.R. ColaM. DutraR.C. Effects of simvastatin beyond dyslipidemia: Exploring its antinociceptive action in an animal model of complex regional pain syndrome-type I.Front. Pharmacol.2017858410.3389/fphar.2017.0058428928655
     [Google Scholar]
  162. KandhareA.D. MukherjeeA.A. BodhankarS.L. Neuroprotective effect of Azadirachta indica standardized extract in partial sciatic nerve injury in rats: Evidence from anti-inflammatory, antioxidant and anti-apoptotic studies.EXCLI J.20171654656528694757
     [Google Scholar]
  163. XiaZ-Y. XieH-T. PanX. ZhaoB. LiuZ.G. Puerarin ameliorates allodynia and hyperalgesia in rats with peripheral nerve injury.Neural Regen. Res.20181371263126810.4103/1673‑5374.23507430028336
     [Google Scholar]
  164. ForteG. GiuffridaV. ScuderiA. PazzagliaM. Future treatment of neuropathic pain in spinal cord injury: The challenges of nanomedicine, supplements or opportunities?Biomedicines2022106137310.3390/biomedicines1006137335740395
     [Google Scholar]
/content/journals/cn/10.2174/1570159X21666230804110858
Loading
The Pharmacological Treatment of Neuropathic Pain in Children
Curr. Neuropharmacol. 22, 38 (2024); https://doi.org/10.2174/1570159X21666230804110858
/content/journals/cn/10.2174/1570159X21666230804110858
/content/journals/cn/10.2174/1570159X21666230804110858
Loading

Data & Media loading...

  • Article Type: Review Article
Keyword(s): analgesia; children; neuralgia; Neuropathic pain; pediatric; pharmacology

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test